Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 21 results.
User Information
Export Records
  1. 1.   Effect of Suppressive Oligodeoxynucleotides on the Development of Inflammation-Induced Papillomas
  2. Ikeuchi, H.; Kinjo, T.; Klinman, D. M.
  3. Cancer Prevention Research. 2011, May; 4(5): 752-757.
  1. 2.   A selective small-molecule nuclear factor-kappa B inhibitor from a high-throughput cell-based assay for "activator protein-1 hits"
  2. Kang, M. I.; Henrich, C. J.; Bokesch, H. R.; Gustafson, K. R.; McMahon, J. B.; Baker, A. R.; Young, M. R.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2009 8(3): 571-581.
  1. 3.   Sulfiredoxin is an AP-1 target gene that is required for transformation and shows elevated expression in human skin malignancies
  2. Wei, Q.; Jiang, H.; Matthews, C. P.; Colburn, N. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2008 105(50): 19738-19743.
  1. 4.   AP-1 a target for cancer prevention
  2. Matthews, C. P.; Colburn, N. H.; Young, M. R.
  3. Current Cancer Drug Targets. 2007, Jun; 7(4): 317-324.
  1. 5.   Fra-1 a target for cancer prevention or intervention
  2. Young, M. R.; Colburn, N. H.
  3. Gene. 2006, Sep; 379: 1-11.
  1. 6.   Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis
  2. Zudaire, E.; Martinez, A.; Garayoa, M.; Pio, R.; Kaur, G.; Woolhiser, M. R.; Metcalfe, D. D.; Hook, W. A.; Siraganian, R. P.; Guise, T. A.; Chirgwin, J. M.; Cuttitta, F.
  3. American Journal of Pathology. 2006, JAN; 168(1): 280-291.
  1. 7.   Peroxisome proliferator-activated receptor beta (delta)-dependent regulation of ubiquitin C expression contributes to attenuation of skin carcinogenesis
  2. Kim, D. J.; Akiyama, T. E.; Harman, F. S.; Burns, A. M.; Shan, W. W.; Ward, J. M.; Kennett, M. J.; Gonzalez, F. J.; Peters, J. M.
  3. Journal of Biological Chemistry. 2004 279(22): 23719-23727.
  1. 8.   Dominant-negative c-Jun (TAM67) target genes: HMGA1 is required for tumor promoter-induced transformation
  2. Dhar, A.; Hu, J.; Reeves, R.; Resar, L. M. S.; Colburn, N. H.
  3. Oncogene. 2004 23(25): 4466-4476.
  1. 9.   Anthocyanidins inhibit activator protein 1 activity and cell transformation: structure-activity relationship and molecular mechanisms
  2. Hou, D. X.; Kai, K.; Li, J. J.; Lin, S. G.; Terahara, N.; Wakamatsu, M.; Fujii, M.; Young, M. R.; Colburn, N.
  3. Carcinogenesis. 2004 25(1): 29-36.
  1. 10.   Nitric oxide does not mediate but inhibits transformation and tumor phenotype
  2. Dhar, A.; Brindley, J. M.; Stark, C.; Citro, M. L.; Keefer, L. K.; Colburn, N. H.
  3. Molecular Cancer Therapeutics. 2003 2(12): 1285-1293.
  1. 11.   AP-1, NF kappa B, and ERK activation thresholds for promotion of neoplastic transformation in the mouse epidermal JB6 model
  2. Suzukawa, K.; Weber, T. J.; Colburn, N. H.
  3. Environmental Health Perspectives. 2002 110(9): 865-870.
  1. 12.   Transactivation of Fra-1 and consequent activation of AP-1 occur extracellular signal-regulated kinase dependently
  2. Young, M. R.; Nair, R.; Bucheimer, N.; Tulsian, P.; Brown, N.; Chapp, C.; Hsu, T. C.; Colburn, N. H.
  3. Molecular and Cellular Biology. 2002 22(2): 587-598.
  1. 13.   AP-1 transrepressing retinoic acid does not deplete coactivators or AP-1 monomers but may target specific Jun or Fos containing dimers
  2. Suzukawa, K.; Colburn, N. H.
  3. Oncogene. 2002 21(14): 2181-2190.
  1. 14.   Decrease in K-ras p21 and increase in Raf1 and activated Erk 1 and 2 in murine lung tumors initiated by N-nitrosodimethylamine and promoted by 2,3,7,8-tetrachlorodibenzo-p-dioxin
  2. Ramakrishna, G.; Perella, C.; Birely, L.; Diwan, B. A.; Fornwald, L. W.; Anderson, L. M.
  3. Toxicology and Applied Pharmacology. 2002 179(1): 21-34.
  1. 15.   Enhancement of N-nitrosodiethylamine-initiated hepatocarcinogenesis by phenytoin in male F344/NCr rats at a dose causing maximal induction of CYP2B
  2. Diwan, B. A.; Henneman, J. R.; Nims, R. W.
  3. International Journal of Toxicology. 2001 20(2): 81-87.
  1. 16.   A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappa B or ODC transactivation
  2. Yang, H. S.; Jansen, A. P.; Nair, R.; Shibahara, K.; Verma, A. K.; Cmarik, J. L.; Colburn, N. H.
  3. Oncogene. 2001 20(6): 669-676.
  1. 17.   Activator protein 1 (AP-1)- and nuclear factor kappa B (NF-kappa B)-dependent transcriptional events in carcinogenesis
  2. Hsu, T. C.; Young, M. R.; Cmarik, J.; Colburn, N. H.
  3. Free Radical Biology and Medicine. 2000 28(9): 1338-1348.
  1. 18.   Difluoromethylornithine chemoprevention of epidermal carcinogenesis in K14-HPV16 transgenic mice
  2. Arbeit, J. M.; Riley, R. R.; Huey, B.; Porter, C.; Kelloff, G.; Lubet, R.; Ward, J. M.; Pinkel, D.
  3. Cancer Research. 1999 59(15): 3610-3620.
  1. 19.   Tumor Promoter Induces High Mobility Group Hmg-Y Protein Expression in Transformation-Sensitive But Not -Resistant Cells
  2. Cmarik, J. L.; Li, Y.; Ogram, S. A.; Min, H. Z.; Reeves, R.; Colburn, N. H.
  3. Oncogene. 1998 16(26): 3387-3396.
  1. 20.   Expression of dominant negative Erk2 inhibits AP-1 transactivation and neoplastic transformation
  2. Watts, R. G.; Huang, C. S.; Young, M. R.; Li, J. J.; Dong, Z. G.; Pennie, W. D.; Colburn, N. H.
  3. Oncogene. 1998 17(26): 3493-3498.
  1. 21.   Tgf-Alpha Sustains Clonal Expansion By Promoter-Dependent, Chemically Initiated Rat Hepatocytes
  2. Kaufmann, W. K.; Byrd, L. L.; Palmieri, D.; Nims, R. W.; Rice, J. M.
  3. Carcinogenesis. 1997 18(7): 1381-1387.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel